Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

TEKNA: TEKNA receives Materials orders worth CAD 1.2 million from American contract manufacturer for medical implants

TEKNARegulatory press release03.11.2026 klo 11.00
Read the release
(Arendal, Norway / Sherbrooke, QC, Canada - 3 November 2026)

Tekna (OSE: TEKNA), a world-leading provider of advanced materials and plasma
systems, is pleased to announce that the company has received significant orders
for titanium metal powder amounting to CAD 1.2 million. The orders are expected
to be delivered throughout 2027.

The orders were placed by a major US-based contract manufacturer of medical
implants. They comprise Ti64 titanium alloy powder in the particle size range
suited to laser powder bed fusion (LPBF), an additive manufacturing process used
to build complex, high-precision components.

"We are pleased to receive these orders, confirming the strong demand for our
powders in medical applications," said Tekna CEO Claude Jean. "The growing use
of advanced implants and wider adoption of additive manufacturing technologies
across the healthcare sector are driving rapid growth in the market for advanced
materials. The orders we have received this quarter further strengthen our
position as a trusted materials supplier to medical device manufacturers."

Suppliers to the medical device industry are typically required to hold
certified quality management systems. Tekna has a well-established track record
in the medical sector, and its Materials business area has recently renewed its
ISO 13485:2016 certification for the design and manufacture of medical devices.
The certification confirms that Tekna's processes, materials and quality system
meet the stringent requirements of medical applications.

Tekna will publish its interim report for the third quarter on November 5, 2026.

ATTACHMENTS
- This announcement in PDF

CONTACTS
Arina Van Oost, Investor Relations | VP Corporate Strategic Development, Tekna
Holding ASA,
+33670115190, investors@tekna.com

ABOUT TEKNA HOLDING ASA
Tekna is a world-leading provider of sustainable, advanced material solutions,
headquartered in Sherbrooke, Canada. The company specializes in high-purity
metal powders used in critical applications such as additive manufacturing (3D
printing) across the aerospace, defense, medical and consumer electronics
industries. The company is positioning itself in the fast-growing market of
advanced nanomaterials for the microelectronics sector.

Tekna also develops cutting-edge induction plasma systems designed for both
industrial research and production. Its unique, IP-protected plasma technology
is powering its hypersonic wind tunnels, PlasmaSonic, which enable simulating
material exposure conditions in space.

With over 30 years of experience, Tekna is a trusted partner to a broad
portfolio of multinational blue-chip customers for its high-quality products and
innovation. Its material solutions help enhance productivity, enable more
efficient use of materials and support the transition to more resilient supply
chains and a circular economy.
https://www.tekna.com

Follow us on LinkedIn: https://www.linkedin.com/company/1358990/ #investinTekna

\
Follow us on LinkedIn: https://www.linkedin.com/company/1358990/ #investinTekna\
\